表纸
市场调查报告书
商品编码
1036792

乳腺癌和前列腺癌成像技术、市场趋势和应用(2021 年)

Imaging Breast & Prostate Cancer - Technologies, Market Trends and Applications, 2021

出版日期: | 出版商: TEMATYS - Exploration of Photonics Markets | 英文 80+ Slides | 商品交期: 最快1-2个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

乳腺癌和前列腺癌是女性和男性中最常见的两种浸润性癌症。

本报告总结了检测和治疗乳腺癌和前列腺癌的现有、新的和不断发展的成像方法。它还提供有关影响医疗保健市场引入新技术和产品的价值链、显著的未来趋势和监管方面的信息。

调查目的/目标

  • 彻底分析乳腺癌和前列腺癌的体内成像方式。
  • 对乳腺癌和前列腺癌成像领域的世界概况、流行率、疾病进展、趋势、法规和现有设施的总结。
  • 详细瞭解所有成像技术及其市场细分。
  • 提供这些癌症成像的产品范围、价值链、现有和未来的市场趋势和预测。
  • 分析价值链中各个利益相关者和影响者的技术和战略。

简介

调查对像:

  • 技术/成像系统 市场数据
  • 体内成像方式
    • 非侵入性(全身/器官)
    • 侵入性(内窥镜)
  • 筛查诊断手术前手术手术后用法基于技术

现有技术

  • 乳房
  • 前列腺

对医疗的期望

概述:现有技术的特点

特点

  • 软组织对比
  • 靈敏度
  • 空间分辨率
  • 深度分辨率
  • 功能
  • 电离辐射
  • 数据收集
  • 成本
  • 安全
  • 用户
  • 兼容性
  • 尺寸
  • 环境安全制约因素

现有技术的现状

  • 抑制器
  • 期望

市场细分

示例视图

细分市场

  • 乳房 X 光检查/X 光 成像

乳腺癌和前列腺癌最常用的成像技术

  • MRI 系统
  • 超声 系统
  • 光学成像(包括PAI)

主要成像系统厂商概览

乳房成像

  • 乳房 X 光检查/X 光
  • 超声波
  • MRI/核医学
  • PAI

前列腺成像

  • X 光
  • 超声波
  • 融合
  • MRI/核医学
  • PAI
  • 光学

财务/公司收购

融资(2015-2021)+重大并购

主要趋势

未来成像系统

  • 待批准的产品
  • 批准的产品

总结

市场/预测/预测

示例视图

目录

第 1 章介绍

第 2 章乳腺癌/前列腺癌事实

  • 流行率
  • 扫瞄/手术

第三章技术细分

  • 现有技术
  • 乳腺癌/前列腺癌成像技术
  • 乳房成像
  • 前列腺成像
  • 对医疗的期望

第 4 章市场数据和趋势

  • 市场细分
  • 主要成像系统概述
  • 制造商
  • 市场和预测
  • 融资/收购一家公司

第 5 章显著的未来研发技术

  • 主要临床试验中心/组织
  • 融资/项目
  • 专利情况
  • 主要趋势

第 6 章监管方面

第 7 章结论

第 8 章关于 TEMATYS

目录

Breast Prostate cancers are the two most common invasive cancers in women and men, respectively This report summarizes existing, new and evolving imaging approaches for detecting and treating Breast Prostate cancers It also includes information on the value chain, noticeable upcoming trends and regulatory aspects that impact introduction of new technologies and products into the medical market.

STUDY GOALS AND OBJECTIVES

  • To provide a thorough analysis of the in vivo* imaging modalities for BREAST and PROSTATE cancer.
  • To summarize the global overview, prevalence, disease progression, trends, regulations and existing facilities for Imaging BREAST and PROSTATE Cancer.
  • To detail and describe all the imaging technologies and its market segmentation.
  • To provide the product range, value chain, existing and upcoming market trends and forecast for imaging these cancers.
  • To analyse the technologies and strategies of the various actors and influencers in the value chain.

INTRODUCTION

In the report:

  • TECHNOLOGY/IMAGING SYSTEMS for Market Data.
  • In vivo IMAGING MODALITIES including:
    • NON INVASIVE (whole body/organ)
    • INVASIVE (endoscopy)
  • Technologies based on use for SCREENING, DIAGNOSIS, PRE-SURGERY, SURGERY and POST-SURGERY.
  • ex vivo*+ techniques used in intra operative imaging for Breast & Prostate cancer.

*ex vivo imaging techniques used in other stages of disease progression have not been discussed in this report.

EXISTING TECHNOLOGIES

  • BREAST
  • PROSTATE

MEDICAL EXPECTATIONS

OVERVIEW: FEATURES OF EXISTING TECHNOLOGIES

CHARACTERISTICS

  • Soft-tissue contrast
  • Sensitivity
  • Spatial resolution
  • Depth resolution
  • Function
  • Ionizing radiation
  • Data acquisition
  • Cost
  • Safety
  • User-friendliness
  • Size
  • Environmental Safety Constraints

CURRENT SITUATION OF EXISTING TECHNOLOGIES

  • CONSTRAINTS
  • EXPECTATIONS

MARKET SEGMENTATION

SAMPLE VIEW

MARKET BREAKDOWN

  • Mammography/X-ray imaging is almost exclusively used for Breast cancer diagnosis/screening (while only under 5% of prostate cancer imaging is done using X-ray/CT/PET-CT).

Breast & Prostate cancers with
their most used imaging techniques

  • MRI systems are used extensively to extract substantial information from soft tissues And thus, general MRI systems can be adapted and used to image both the Breast as well as the Prostate.
  • Ultrasound systems are also the preferred imaging choice for varied Breast and Prostate cancers, concluding that general Ultrasound systems can be used and adapted with right transducers and probes.
  • Optical imaging (including PAI) is gaining popularity for pre and intra operative imaging procedures, and thus forms a 4th market segment for Breast and Prostate imaging.
  • Hence, when we speak of a 'Breast Cancer/Prostate Cancer Imaging Market', it is only logical to look into these market segments namely: Mammography/X-ray, MRI, Ultrasound and Optical imaging.

*Prostate cancer imaging market might not be a standalone market, but actually co-exists with the bladder/colon/rectum/gynaecological imaging market especially when it comes to ultrasound imaging We could also call it 'Lower-abdominal Imaging market' for simplicity.

OVERVIEW OF KEY IMAGING SYSTEMS' MANUFACTURERS

BREAST IMAGING

  • MAMMOGRAPHY/X-RAY
  • TEMATYS - Exploration of Photonics Markets
  • ULTRASOUND
  • MRI/NUCLEAR MEDICINE
  • PAI

PROSTATE IMAGING

  • X-RAY
  • TEMATYS - Exploration of Photonics Markets
  • ULTRASOUND
  • FUSION
  • MRI/NUCLEAR MEDICINE
  • PAI
  • OPTICAL

FINANCE & TAKEOVERS

FUNDRAISING (2015-2021) + MAIN MERGERS ACQUISITIONS

  • FUNDRAISING >$ 1M
  • MERGERS AND ACQUISITIONS

MAJOR TRENDS

IMMINENT IMAGING SYSTEMS

  • PRODUCTS AWAITING APPROVAL
  • APPROVED PRODUCTS

SUMMARY

MARKET & FORECAST & PERSPECTIVES

SAMPLE VIEW

TABLE OF CONTENTS

1. INTRODUCTION

  • Study Goals and Objectives
  • Information sources and methodology
  • Scope of the report
  • Glossary
  • Definitions
  • List of companies mentioned in the report

2. BREAST PROSTATE CANCER FACTS

  • Prevalence
  • Scanning & Surgeries

3. TECHNOLOGY SEGMENTATION

  • Existing Technologies
  • Imaging Techniques for Breast & Prostate Cancer
  • Breast Imaging
  • Prostate Imaging
  • Medical Expectations

4. MARKET DATA AND TRENDS

  • Market Segmentation
  • Overview of Key Imaging Systems'
  • manufacturers
  • Market and Forecast
  • Finance & Takeovers

5. NOTICEABLE UPCOMING R D TECHNOLOGIES

  • Major centres / organisations for clinical trials
  • Funding / Projects
  • Patents' Landscape
  • Major Trends

6. REGULATORY ASPECTS

7. CONCLUSIONS

8. ABOUT TEMATYS